FDA/ORA Bioresearch Monitoring Information Page
|
|
|
|
|
|
|
Compliance Policy Guides - Bimo Related:
100.900
|
International Memoranda of Understanding (June, 1995) Link to FDA International Program WebSite |
120.100
|
Fraud, Untrue Statements of Material Facts, Bribery, and
Illegal Gratuities (CPG 7150.09) (July, 1991) |
130.300
|
FDA Access to Results of Quality Assurance Program Audits and
Inspections (CPG 7151.02) (Jan. 1996) |
|
|
|
|
Guidance for Industry:
Good Laboratory
Practice Regulations Management Briefings Post Conference Report |
Aug. 1979 (HTML) |
n/a |
GLP Questions and Answers |
HTML |
52 KB |
Computerized Systems Used In Clinical Trials |
Apr. 1999 (HTML) |
46 KB |
Guideline for the Monitoring of Clinical Investigations |
Jan. 1988 (HTML) |
PDF,16kb |
Draft Guidance: Exception from Informed Consent-Emergency Research |
July 2006
| 2.86 MB |
|
|
|
-
Part 50--PROTECTION OF HUMAN SUBJECTS |
(HTML) |
Part 56--INSTITUTIONAL REVIEW BOARDS |
(HTML) |
Part 58--GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES |
(HTML) |
Part 312--INVESTIGATIONAL NEW DRUG APPLICATION |
(HTML) |
Part 320--BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS |
(HTML) |
Part 511--NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE |
(HTML) |
Part 812--INVESTIGATIONAL DEVICE EXEMPTIONS |
(HTML) |
|
|
Good Laboratory Practice (GLP) Resources:
Comparison Chart of FDA, Environmental Protection Agency (EPA), and Organization for Economic Co-operation and Development (OECD) |
HTML |
1.79 mb |
Good Laboratory Practice (GLP), Proposed Rule,
11/19/1976 |
HTML N/A |
6170 KB |
Good Laboratory Practice
(GLP) Final Rule, 12/22/1978 |
HTML N/A |
8355 KB |
Good Laboratory Practice (GLP), Proposed Rule,
10/29/1984 |
HTML N/A |
1762 KB |
Good Laboratory Practice (GLP), Amendment, Final
Rule, 9/4/1987 |
HTML N/A |
3167 KB |
OECD GLP Internet
(Organization for Economic
Co-operation and Development) (Link to an external site, not
part of the FDA web) |
|
|